Heart Failure
📧 Sign up to get email alerts when something new happens for Heart Failure.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2009-02-18Clinical Trial Update: Progenitor Cell Therapy in Dilative Cardiomyopathy [Phase 1, Phase 2]
The update indicates that Phase 1 and Phase 2 trials of progenitor cell therapy for dilated cardiomyopathy presenting as heart failure have …
-
CLINICAL_TRIALS research · 2009-02-16Clinical Trial Update: Association of Multiple CardiOvascular Risk Factors and Erectile Function Across Europe
This clinical trial update investigates the association between multiple cardiovascular risk factors and erectile function across Europe, sp…
-
CLINICAL_TRIALS trial_result · 2009-02-11Clinical Trial Update: The Effect of Eplerenone and Atorvastatin on Markers of Collagen Turnover in Diastolic Heart Failure [NA]
A completed clinical trial evaluating the effect of eplerenone and atorvastatin on markers of collagen turnover in diastolic heart failure.
-
FDA approval · 2009-02-06FDA Approved: FUROSEMIDE — Supplemental Application (Chartwell RX, LLC)
The FDA approved a supplemental application for furosemide submitted by Chartwell RX, LLC.
-
CLINICAL_TRIALS trial_result · 2009-02-05Clinical Trial Update: The Effect of Ischemic Training on Exercise Endurance [NA]
Clinical trial update indicating completion of a study on ischemic training and its effect on exercise endurance in heart failure and cardio…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2009-02-04Clinical Trial Update: IVIg Therapy for Patients With Idiopathic Cardiomyopathy and Endomyocardial Biopsy Proven High PVB19 Viral Load [Phase 1]
Clinical trial update on a Phase 1 study of intravenous immunoglobulin therapy for patients with idiopathic cardiomyopathy and biopsy-proven…
-
CLINICAL_TRIALS research · 2009-02-04Clinical Trial Update: Randomised Trial of Health Coaching in Secondary Prevention of Diabetes and Heart Disease [Phase 3]
This is a Phase 3 randomized trial evaluating health coaching for secondary prevention of Type 2 diabetes mellitus and heart disease. The cu…
-
CLINICAL_TRIALS trial_result · 2009-01-30Clinical Trial Update: Safety & Efficacy of ALT-711 (Alagebrium) in Chronic Heart Failure [Phase 2]
This trial update reports termination of a Phase 2 study evaluating the safety and efficacy of ALT-711 (alagebrium) in chronic heart failure…
-
CLINICAL_TRIALS trial_result · 2009-01-30Clinical Trial Update: Study to Evaluate Cardiac Hemodynamics and Safety of SLV320 in Subjects With Congestive Heart Failure [Phase 2]
This document notes the completion of a Phase 2 study evaluating the cardiac hemodynamics and safety of SLV320 in subjects with congestive h…
-
FDA approval · 2009-01-30FDA Approved: AMILORIDE HYDROCHLORIDE — Original Application (Sigmapharm Laboratories, LLC)
FDA approves Sigmapharm Laboratories, LLC's amiloride hydrochloride as an original generic application (ANDA) product space.
-
CLINICAL_TRIALS trial_result · 2009-01-29Clinical Trial Update: Effects of Growth Hormone on Exercise Capacity [Phase 3]
Phase 3 clinical trial evaluating growth hormone on exercise capacity in chronic heart failure has completed. Sponsor: Federico II Universit…
-
CLINICAL_TRIALS trial_result · 2009-01-27Clinical Trial Update: Study of Coronary Artery Disease by Two Types of Angiography [NA]
Trial comparing two types of angiography for coronary artery disease in patients with congestive heart failure has completed.
-
FDA approval · 2009-01-27FDA Approved: TORSEMIDE — Original Application (Camber Pharmaceuticals, Inc.)
FDA approved Camber Pharmaceuticals' generic torsemide (Original Application), authorizing the generic torsemide tablet for edema associated…
-
CLINICAL_TRIALS research · 2009-01-23Clinical Trial Update: Dobutamine Stress Echocardiography in Cardiac Resynchronization Therapy (CRT) Patients Selection
A clinical trial update assessing whether dobutamine stress echocardiography can be used to select heart failure patients for cardiac resync…
-
CLINICAL_TRIALS trial_result · 2009-01-21Clinical Trial Update: Levosimendan in High Risk Heart Valve Surgery [Phase 4]
This document reports the completion of a Phase 4 trial evaluating levosimendan in high-risk heart valve surgery for patients with heart fai…
-
CLINICAL_TRIALS trial_result · 2009-01-19Clinical Trial Update: The Effects of Anodal Stimulation on Echocardiographic Outcome in Patients With Cardiac Resynchronization Therapy [NA]
This clinical trial update examines the effects of anodal stimulation on echocardiographic outcomes in patients receiving cardiac resynchron…
-
CLINICAL_TRIALS trial_result · 2009-01-07Clinical Trial Update: Transforming Psychotherapy for Chronically Ill Patients [Phase 1, Phase 2]
A completed Phase 1/Phase 2 clinical trial evaluating psychotherapy for chronically ill patients, including those with heart failure, COPD, …
-
FDA approval · 2008-12-31FDA Approved: ENALAPRIL MALEATE — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approved a supplemental abbreviated new drug application for enalapril maleate from Heritage Pharmaceuticals (d/b/a Avet Pharmaceuticals…
-
CLINICAL_TRIALS trial_result · 2008-12-25Clinical Trial Update: Study to Evaluate the Safety of Twice Daily Oral Carvedilol [Phase 3]
Phase 3 trial evaluating the safety of twice-daily carvedilol in congestive heart failure has completed.
-
CLINICAL_TRIALS trial_result · 2008-12-25Clinical Trial Update: Safety and Efficacy Study of Carvedilol to Treat Children With Congestive Heart Failure [Phase 3]
Phase 3 study update on carvedilol to treat congestive heart failure in pediatric patients. The update discusses safety and efficacy results…
-
FDA approval · 2008-12-23FDA Approved: ENALAPRILAT — Original Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved Hikma Pharmaceuticals USA Inc.'s original application for Enalaprilat (ENALAPRILAT), a generic ACE inhibitor, expanding ava…
-
FDA approval · 2008-12-22FDA Approved: CARVEDILOL — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for carvedilol submitted by Teva Pharmaceuticals USA, Inc. (carvedilol).
-
FDA approval · 2008-12-19FDA Approved: COREG CR — Original Application (Waylis Therapeutics LLC)
The FDA approves COREG CR (carvedilol phosphate) from Waylis Therapeutics LLC under an Original Application, introducing an extended-release…
-
FDA approval · 2008-12-19FDA Approved: COREG CR — Supplemental Application (Waylis Therapeutics LLC)
FDA approves Waylis Therapeutics LLC's supplemental application for COREG CR (carvedilol phosphate). This action updates the product under a…
-
CLINICAL_TRIALS trial_result · 2008-12-18Clinical Trial Update: Restoring Sinus Rhythm With Cardiac Resynchronization in Patients With Atrial Fibrillation (ReSync AF) [NA]
The ReSync AF trial evaluating cardiac resynchronization therapy to restore sinus rhythm in patients with heart failure and atrial fibrillat…